A Novel 14mer Peptide Inhibits Autophagic Flux via Selective Activation of the mTORC1 Signalling Pathway: Implications for Alzheimer’s Disease
Cloe García Porta, Kashif Mahfooz, Joanna Komorowska, Sara Garcia-Rates, Susan Greenfield, Manuela Dicarlo · 2024
Read A Novel 14mer Peptide Inhibits Autophagic Flux via Selective Activation of the mTORC1 Signalling Pathway: Implications for Alzheimer’s Disease by Cloe García Porta, Kashif Mahfooz, Joanna Komorowska, Sara Garcia-Rates, Susan Greenfield, Manuela Dicarlo (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11641777.txt.
Description
Cloe García Porta and co-authors study a small peptide and its role in cell cleanup failure in Alzheimer's disease in 2024. The peptide guides cell growth in early life. In the adult brain it may turn harmful. It acts at a known cell receptor. Past work ties it to a growth pathway that is overactive in this disease.
In human brain tissue, the peptide rose as the disease advanced. Cleanup bags in cells fell in step. In lab tests, the peptide raised the pathway's activity and led to waste build up. A blocked form of the peptide restored normal cleanup. The same held in mouse brain slices. The authors see the peptide as a driver of nerve cell loss.
Catalog record
| CREATOR | Cloe García Porta, Kashif Mahfooz, Joanna Komorowska, Sara Garcia-Rates, Susan Greenfield, Manuela Dicarlo |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |